Lv7
5010 积分 2021-06-04 加入
Updates in the Management of Immune-Mediated Necrotizing Myopathy
7个月前
已关闭
Efficacy and safety of rademikibart (CBP-201), a next-generation mAb targeting IL-4Rα, in adults with moderate to severe atopic dermatitis: A phase 2 randomized trial (CBP-201-WW001)
8个月前
已完结
Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb
8个月前
已完结
Dupilumab treatment improves quality of life in adult patients with moderate‐to‐severe atopic dermatitis: results from a randomized, placebo‐controlled clinical trial
8个月前
已完结
what is the optimal sequential therapy after secondary IL-17A inhibitor failure in psoriasis swiching to an IL-23 inhibitor or to another IL-17A inhibitor
8个月前
已完结
Therapeutic targeting of the IL-13 pathway in skin inflammation
9个月前
已完结
24-Week Real-World Effectiveness and Safety of Lebrikizumab for Atopic Dermatitis in Japan: An Analysis Stratified by Prior Systemic Therapy
10个月前
已完结
Atopic dermatitis
10个月前
已完结
Treatment of interstitial lung disease in systemic sclerosis: guidelines and new clinical trial results
10个月前
已完结
Gastrointestinal disease in systemic sclerosis: the neglected organ system?
10个月前
已关闭
皖公网安备34019202002308
